Praxis Precision Medicines logo
Praxis Precision Medicines PRAX
$ 283.56 3.0%
report update icon

Quarterly report 2026-Q2
added 08-06-2026

Praxis Precision Medicines General and Administrative Expenses | PRAX

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.
What these expenses include
  • Salaries of administrative staff (executives, HR, accountants, legal personnel)
  • Office rent and utilities
  • Office equipment and IT infrastructure
  • Professional services (auditors, lawyers, consultants)
  • Insurance
  • General administrative travel and representation expenses
What the metric indicates
  • Cost control
    A high level of such expenses may indicate inefficient management or an overly complex structure
  • Profitability
    Reducing administrative expenses while maintaining stable revenue increases operating profit
  • Comparative analysis
    Investors can compare this metric as a percentage of revenue among companies in the same industry
  • Business flexibility
    Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Praxis Precision Medicines

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
59.1 M 56.3 M 42.1 M 59.9 M 47.1 M 17 M 6.23 M 3.9 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
59.9 M 3.9 M 36.4 M

Quarterly General and Administrative Expenses Praxis Precision Medicines

2026-Q2 2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
27.5 M 27.9 M 12.6 M 13.1 M 13.9 M - 15.3 M 10.6 M 15.3 M - 8.72 M 10.1 M 13.3 M - 13.9 M 16.8 M 16.2 M - 11.6 M 10.8 M 9.49 M - 3.43 M 2.52 M 1.6 M - 1.31 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
27.9 M 1.31 M 12.2 M

General and Administrative Expenses of other stocks in the Biotechnology industry

Issuer General and Administrative Expenses Price % 24h Market Cap Country
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
191 M $ 84.95 0.13 % $ 7.99 B usaUSA
Cyclerion Therapeutics Cyclerion Therapeutics
CYCN
2.48 M $ 34.99 3.77 % $ 147 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
3.64 M $ 4.63 21.05 % $ 20 M israelIsrael
BioXcel Therapeutics BioXcel Therapeutics
BTAI
20.5 M $ 0.07 9.81 % $ 855 K usaUSA
Theravance Biopharma Theravance Biopharma
TBPH
73.7 M $ 17.03 0.03 % $ 857 M cayman-islandsCayman-islands
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
4.66 M - -1.52 % $ 24.7 M usaUSA
Forte Biosciences Forte Biosciences
FBRX
12.4 M $ 76.99 0.03 % $ 997 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
13.4 M - -45.71 % $ 1.2 M canadaCanada
Cleveland BioLabs, Inc. Cleveland BioLabs, Inc.
CBLI
2.16 M - -7.31 % $ 49 M usaUSA
Five Prime Therapeutics, Inc. Five Prime Therapeutics, Inc.
FPRX
40.6 M - - $ 1.77 B usaUSA
Biofrontera AG Biofrontera AG
BFRA
9.15 M - -8.24 % $ 105 M germanyGermany
Catabasis Pharmaceuticals, Inc. Catabasis Pharmaceuticals, Inc.
CATB
11.8 M - -6.97 % $ 657 M usaUSA
China Biologic Products Holdings, Inc. China Biologic Products Holdings, Inc.
CBPO
83.4 M - 1.68 % $ 4.65 B chinaChina
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc.
FLXN
105 M - - $ 459 M usaUSA
Heat Biologics, Inc. Heat Biologics, Inc.
HTBX
15 M - -5.76 % $ 99.8 M usaUSA
Kindred Biosciences, Inc. Kindred Biosciences, Inc.
KIN
22 M - 0.11 % $ 419 M usaUSA
Shineco, Inc. Shineco, Inc.
TYHT
9.22 M - -3.90 % $ 97.2 M chinaChina
Intec Pharma Ltd Intec Pharma Ltd
NTEC
7.09 M - -12.45 % $ 17.7 M israelIsrael
Progenity, Inc. Progenity, Inc.
PROG
75.4 M - -3.47 % $ 164 M usaUSA
Strongbridge Biopharma plc Strongbridge Biopharma plc
SBBP
40.9 M - 1.52 % $ 136 M usaUSA
Seneca Biopharma, Inc. Seneca Biopharma, Inc.
SNCA
8.67 M - -1.19 % $ 28.7 M usaUSA
Celsion Corporation Celsion Corporation
CLSN
6.87 M - -6.63 % $ 13.9 M usaUSA
I-Mab I-Mab
IMAB
453 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.4 B - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
16.2 M - 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
5.49 M - -13.47 % $ 169 M franceFrance
CureVac N.V. CureVac N.V.
CVAC
69.7 M - - $ 867 M germanyGermany
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
24.5 M - 0.74 % $ 768 M israelIsrael
Abcam plc Abcam plc
ABCM
224 M - - $ 4.9 B britainBritain
Midatech Pharma plc Midatech Pharma plc
MTP
4.95 M - -18.52 % $ 27.3 M britainBritain
MorphoSys AG MorphoSys AG
MOR
65.8 M - 2.43 % $ 254 M germanyGermany
Affimed N.V. Affimed N.V.
AFMD
24.7 M - -34.95 % $ 21.5 M germanyGermany
AnPac Bio-Medical Science Co., Ltd. AnPac Bio-Medical Science Co., Ltd.
ANPC
7.25 M - -1.58 % $ 28.1 M chinaChina
Celyad Oncology SA Celyad Oncology SA
CYAD
10.5 M - - $ 12.5 M belgiumBelgium
Gracell Biotechnologies Gracell Biotechnologies
GRCL
139 M - - $ 3.37 B chinaChina
Galapagos NV Galapagos NV
GLPG
147 M - - $ 1.83 B belgiumBelgium
Teligent, Inc. Teligent, Inc.
TLGT
23.4 M - -13.85 % $ 16.1 M usaUSA
Viela Bio, Inc. Viela Bio, Inc.
VIE
60.2 M - - $ 2.91 B usaUSA
Aphria Inc. Aphria Inc.
APHA
164 M - -0.45 % $ 4.87 B canadaCanada
Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals, Inc.
ARPO
8.76 M - -0.90 % $ 104 M usaUSA
Chiasma, Inc. Chiasma, Inc.
CHMA
39.6 M - -6.00 % $ 238 M usaUSA
Adamas Pharmaceuticals, Inc. Adamas Pharmaceuticals, Inc.
ADMS
107 M - - $ 376 M usaUSA
Cellect Biotechnology Ltd. Cellect Biotechnology Ltd.
APOP
10.2 M - 0.38 % $ 12.9 M israelIsrael
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.
AZRX
7.29 M - 2.07 % $ 34.4 M usaUSA
Cerecor Inc. Cerecor Inc.
CERC
17.4 M - -1.68 % $ 283 M usaUSA
Constellation Pharmaceuticals, Inc. Constellation Pharmaceuticals, Inc.
CNST
29.3 M - - $ 1.63 B usaUSA
Auris Medical Holding Ltd. Auris Medical Holding Ltd.
EARS
2.6 M - -1.77 % $ 39.2 M bermudaBermuda
Dicerna Pharmaceuticals, Inc. Dicerna Pharmaceuticals, Inc.
DRNA
72.1 M - 0.34 % $ 2.98 B usaUSA